Zepp Health Corp (ZEPP): R&D Expense
Older than the company's other figures. The latest R&D Expense is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
361.81M CNY
Year ended 2023-12-31
-12.4%
3-year compound annual growth
+6.6%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | 361.81M CNY | -30.0% | 2024-04-23, From 2023-01-01 |
| 2022-12-31 | 517.12M CNY | +0.4% | 2024-04-23, From 2022-01-01 |
| 2021-12-31 | 515.08M CNY | -4.3% | 2024-04-23, From 2021-01-01 |
| 2020-12-31 | 538.01M CNY | +24.9% | 2023-04-24, From 2020-01-01 |
| 2019-12-31 | 430.82M CNY | +63.7% | 2022-04-28, From 2019-01-01 |
| 2018-12-31 | 263.22M CNY | +71.1% | 2021-04-19, From 2018-01-01 |
| 2017-12-31 | 153.83M CNY | +16.3% | 2020-04-23, From 2017-01-01 |
| 2016-12-31 | 132.30M CNY | +114.9% | 2019-04-12, From 2016-01-01 |
| 2015-12-31 | 61.55M CNY | n/a | 2018-04-27, From 2015-01-01 |